Elan

Perrigo to purchase Elan for US$8.6 billion

Perrigo Company announced today that it has signed a definitive acquisition agreement to acquire Irish drug firm Elan Corporation.

Read Full Article

Royalty to Explore Ways to Bid for Elan with Partner

Royalty Pharma held internal discussions about making a new bid for Elan Corp according to four sources.

Read Full Article

Forest Laboratories Considers Bid for Elan Corp

According to sources, Icahn-backed Forest Laboratories is among mid-sized drug makers to eye for Elan.

Read Full Article

Elan Shareholders Favor Share Buyback

On Monday, Elan shareholders approved a share buyback and put itself up for sale on Friday.

Read Full Article

US$2 Billion Risk for Elan If Royalty Pharma Walks Away

Elan is at risk of losing US$2 billion market value once Royalty Pharma walks away with its takeover deal.

Read Full Article

UPDATE: Elan Rejects Fresh Bid from Royalty

Elan rejects the newest bid from Royalty and seeks to look at other unsolicited interested parties.

Read Full Article

Royalty Pharma Urges NY Federal Court to Proceed With Elan Bid

Royalty Pharma urged the federal court in New York to lift the temporary restraining order it has ordered for the Royalty-Elan bid.

Read Full Article

Royalty Pharma Increases Bid For Elan to US$8 Billion

Royalty Pharma raised its hostile bid for Irish drug firm, Elan from US$12.50 to US$13.

Read Full Article

Royalty Pharma Offers US$6.6Bln Offer for Elan

Royalty Pharma offers US$11 per Elan share.

Read Full Article

Subscribe to VCpost newsletter

Sign up for our Deals of the Day newsletter.
We will not spam you!

Real Time Analytics